NeuroMetrix Inc. (NASDAQ: NURO) is -53.49% lower on its value in year-to-date trading and has touched a low of $0.81 and a high of $6.20 in the current 52-week trading range. The NURO stock was last observed hovering at around $1.97 in the last trading session, with the day’s gains setting it 0.03% off its average median price target of $50.00 for the next 12 months. It is also 96.0% off the consensus price target high of $50.00 offered by 1 analysts, but current levels are 96.0% higher than the price target low of $50.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $2.00, the stock is -1.48% and -4.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 1.52% at the moment leaves the stock -28.32% off its SMA200. NURO registered -53.16% loss for a year compared to 6-month loss of -45.50%. The firm has a 50-day simple moving average (SMA 50) of $2.0274 and a 200-day simple moving average (SMA200) of $2.4160.
The stock witnessed a 12.36% gain in the last 1 month and extending the period to 3 months gives it a -39.94%, and is -10.31% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.37% over the week and 12.38% over the month.
NeuroMetrix Inc. (NURO) has around 23 employees, a market worth around $7.94M and $8.30M in sales. Profit margin for the company is -77.90%. Distance from 52-week low is 146.31% and -67.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-152.70%).
NeuroMetrix Inc. (NURO) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for NeuroMetrix Inc. (NURO) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
NeuroMetrix Inc. quarterly earnings per share for the current quarter are estimated at $0., but quarterly earnings will post 96.20% year-over-year.
NeuroMetrix Inc. (NURO) Top Institutional Holders
10 institutions hold shares in NeuroMetrix Inc. (NURO), with 32.62k shares held by insiders accounting for 1.19% while institutional investors hold 5.90% of the company’s shares. The shares outstanding are 3.47M, and float is at 2.70M with Short Float at 6.98%. Institutions hold 5.83% of the Float.
NeuroMetrix Inc. (NURO) Insider Activity
A total of 10 insider transactions have happened at NeuroMetrix Inc. (NURO) in the last six months, with sales accounting for 0 and purchases happening 10 times. The most recent transaction is an insider purchase by Gozani Shai, the company’s President & CEO. SEC filings show that Gozani Shai bought 1,000 shares of the company’s common stock on Jun 11 at a price of $1.84 per share for a total of $1840.0. Following the purchase, the insider now owns 24630.0 shares.
NeuroMetrix Inc. disclosed in a document filed with the SEC on May 21 that Gozani Shai (President & CEO) bought a total of 500 shares of the company’s common stock. The trade occurred on May 21 and was made at $2.33 per share for $1165.0. Following the transaction, the insider now directly holds 23630.0 shares of the NURO stock.
Still, SEC filings show that on May 14, Gozani Shai (President & CEO) acquired 1,000 shares at an average price of $2.18 for $2180.0. The insider now directly holds 23,130 shares of NeuroMetrix Inc. (NURO).